OBJECTIVE: Chorioamnionitis is a risk factor for perinatal HIV transmission and early-onset neonatal sepsis. Placental inflammation increases risk of HIV transmission. The objective of this study is to explore the risk of histologic chorioamnionitis in HIV-1 positive subjects undergoing induction of labor with and without mechanical dilation. STUDY DESIGN: This is a multi-center retrospective cohort study of HIV positive women who underwent induction/augmentation of labor from 11/2010 e 8/2017 at two major tertiary care centers in different states. Delivery outcomes including: histologic and clinical chorioamnionitis, postpartum endometritis, and neonatal HIV infection were included for analysis. A bivariate analysis of demographic, HIV specific, and delivery outcome measures between the cohorts was conducted. Multivariate logistical regression modeling was used to control for possible confounding variables. RESULTS: A total of 396 HIV+ women delivered during the study period. 135 women met inclusion criteria and 95 had placental pathology available for review. 83 women (61.5%) underwent mechanical dilation and 51 (38.5%) had no mechanical dilation. The cohorts were similar in terms of race/ethnicity, age, parity, HIV viral load, CD4 count, and GBS status. The mechanical dilation cohort had less cervical dilation on admission compared to the control. 20 subjects had histologic chorioamnionitis (21.05%). There was no difference in rates of histologic chorioamnionitis between the cohorts with 14 (22.22%) of the mechanical dilation cohort and 6 (18.75%) of the no mechanical dilation cohort having evidence of histologic chorioamnionitis (p ¼ 0.6951, OR 1.24 OBJECTIVE: Elective cesarean delivery has been shown to decrease vertical mother-to-child transmission (MTCT) of HIV in women with viral load (VL) >1000 copies/mL. HIV+ women who present late in pregnancy may not have viral load quantification prior to delivery. Our study investigated the costs and outcomes of using a point-of-care (POC) HIV RNA VL test to inform mode of delivery versus cesarean section for all (CS all) in HIV+ pregnant women without prenatal care. STUDY DESIGN: A decision-analytic model was constructed using TreeAge software to compare Xpert HIV-1 VL test versus CS all in HIV+ women without prenatal care who presented at term for delivery. We used a theoretical cohort of 1,275 women, the estimated population of HIV+ women without prenatal care in the US annually. The average cost per Xpert test for our cohort was $15.03. We assumed all women proceeded to a second delivery with undetectable VL, reflecting the average number of births per US woman. Primary outcomes included neonatal HIV transmission, mode of delivery, and cesarean-related complications, in addition to cost and quality-adjusted life years (QALYs). All probabilities, costs, and utilities were derived from literature and varied using sensitivity analyses. A cost-effectiveness threshold was set at $100,000/QALY. RESULTS: In our theoretical cohort, quantifying VL to guide mode of delivery resulted in more HIV+ neonates as compared to immediate CS all (Table) . The increased rate of MTCT in this strategy results from fewer cesarean deliveries. There were no observed maternal deaths or differences in cesarean-related complications, including hysterectomy and uterine rupture, between the two strategies. Quantifying VL prior to delivery would increase cost by $3,142,940 and decrease QALYs by 74 as compared to CS all in the setting of unknown VL. The rapid VL test requires 99.9% sensitivity in order to be cost-effective. With the threshold set at $100,000/QALY, the POC HIV RNA VL test is cost-effective only when the proportion of women with high VL is below 12% (Figure) . CONCLUSION: For HIV+ pregnant women without prenatal care in the US, utilizing a POC HIV RNA VL test to guide mode of delivery is not cost-effective when compared to CS for all women even when including the downstream impact of a cesarean delivery. Our model underscores the importance of prenatal antiretroviral treatment to decrease MTCT. Additionally, POC HIV RNA VL tests require greater examination and study in obstetric populations.
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Poster Session III 
OBJECTIVE:
We aimed to compare the association of maternal ethnicity on the risk of brachial plexus injuries between pregnancies complicated by shoulder dystocia to those unaffected. STUDY DESIGN: This is a retrospective cohort study of nulliparous and multiparous women with term deliveries in the state of California between 2007 and 2011 using linked vital statistics and ICD-9 data. We compared brachial plexus injuries in pregnancies complicated by shoulder dystocia to those unaffected and stratified by maternal ethnicity. We used chi-square tests to compare outcomes and multiple logistic regression to estimate adjusted odds ratio (aOR) while controlling for birth weight. RESULTS: Our cohort consisted of 24,509 pregnancies complicated by shoulder dystocia, of which 961 fetuses had brachial plexus injuries, and 1,480,844 pregnancies unaffected by shoulder dystocia, of which 1,918 fetuses had brachial plexus injuries. African American women with deliveries complicated by shoulder dystocia experienced a higher rate of brachial plexus injuries while African American women with deliveries unaffected by shoulder dystocia experienced a decrease in brachial plexus injuries. The aOR for African American women with shoulder dystocia was 2.53 (95% CI: 1.83-3.49) and without shoulder dystocia 0.67 (95% CI: 0.53-0.86). This effect was similarly observed in Asian women. The aOR for Asian women with shoulder dystocia was 1.47 (95% CI: 1.09-1.97) and without shoulder dystocia 0.25 (95% CI: 0.19-0.33). CONCLUSION: In pregnancies complicated by shoulder dystocia, African American and Asian women have increased rates of fetal brachial plexus injury compared to women of similar ethnicity without pregnancies affected by shoulder dystocia. This data suggests additional research of obstetric outcomes in select populations is warranted.
622 Trends in antibiotic use with third and fourth degree perineal lacerations OBJECTIVE: A single dose of broad-spectrum antibiotics is recommended at the time of repair of obstetric anal spincter injuries (OASIS). We sought i) to report on antibiotic use for 3rd and 4th degree lacerations, ii) to report trends in such use over time, and iii) to analyze patient and hospital characteristics associated with receipt of antibiotics. STUDY DESIGN: An administrative inpatient database that includes medications was analyzed to evaluate receipt of antibiotics in women with OASIS. Women were eligible for inclusion if they had a delivery hospitalization between January 2006 to March 2015 and a 3rd or 4th degree perineal laceration. Women were excluded if they had a cesarean delivery, chorioamnionitis, endometritis, or Group B strep colonization. Our primary outcome was receipt of any antibiotic associated with either 3rd or 4th degree laceration. Secondary outcomes included receipt of any antibiotic for 3rd vs. 4th degree laceration, type of antibiotic, and antibiotic use over time. Unadjusted and adjusted log linear models were created analyzing the role of patient demographics and hospital-level characteristics in receipt of antibiotics in women with OASIS. RESULTS: Among 92,320 women with OASIS included in this analysis, 37.2% received antibiotics. Women with 4th degree lacerations were 1.4 times more likely to receive antibiotics than women with 3rd degree lacerations (48.6% vs. 34.3%, p<0.01). The most common antibiotic associated with 3rd and 4th degree lacerations was erythromycin (47.2%), followed by ampicillin (22.8%) and cefazolin (20.2%). Over the study period use of antibiotics for OASIS decreased significantly (Figure 1) . In adjusted analysis, 4th degree laceration, black race, public insurance, increasing comorbidity, urban hospitals, non-teaching hospitals, larger hospitals, and region outside the Northeast were all significantly associated with receipt of antibiotics (Table 1) . CONCLUSION: Using a national inpatient sample, we found receipt of antibiotics in the setting of OASIS was less than 50%. Use of antibiotics in this setting decreased over the study period and varied significantly based on patient and hospital characteristics. Further research is needed to clarify this finding in light of current recommendations for antibiotic prophylaxis.
